Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes

被引：0
|
作者：
Gong, Y. [1 ]
Mu, Y. [2 ]
Fan, B. [3 ]
Hehnke, U. [1 ]
Pan, C. [2 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[3] Boehringer Ingelheim China Investment Co Ltd, Shanghai, Peoples R China
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
807
引用
收藏
页码：S388 / S388
页数：1
相关论文
共 50 条
  • [41] Fixed-dose combinations in type 2 diabetes - role of the canagliflozin metformin combination
    Fleming, Joshua W.
    Fleming, Laurie W.
    Davis, Courtney S.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 287 - 294
  • [42] Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview
    Jaime A. Davidson
    Lance Sloan
    [J]. Advances in Therapy, 2017, 34 : 41 - 59
  • [43] Initial Therapy with the Fixed-Dose Combination of Sitagliptin and Metformin Results in Greater Improvement in Glycemic Control Compared with Pioglitazone in Patients with Type 2 Diabetes
    Katz, Leonid
    Xu, Lei
    Hussain, Shehla
    Golm, Gregory T.
    O'Neill, Edward A.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Williams-Herman, Debora E.
    [J]. DIABETES, 2010, 59 : A148 - A149
  • [44] Linagliptin/metformin HCl (fixed combination therapy) for the treatment of Type 2 diabetes mellitus
    Bhargava, Amit
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (04) : 353 - 363
  • [45] Efficacy of vildagliptin in drug-naive patients with type 2 diabetes
    Dejager, S.
    Baron, M. A.
    Razac, S.
    Foley, J. E.
    Dickinson, S.
    Schweizer, A.
    [J]. DIABETOLOGIA, 2006, 49 : 479 - 480
  • [46] Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naive patients with type 2 diabetes: a randomized, double-blind, 6-month study
    Pratley, R. E.
    Fleck, P.
    Wilson, C.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 613 - 621
  • [47] Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Garber, A.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (05): : 436 - 437
  • [48] Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial
    Guo, Li-xin
    Wang, Lian-wei
    Tian, De-zeng
    Xu, Feng-mei
    Huang, Wei
    Wu, Xiao-hong
    Zhu, Wei
    Chen, Jun-Qiu
    Zheng, Xin
    Zhou, Hai-Yan
    Li, Hong-Mei
    He, Zhong-Chen
    Wang, Wen-Bo
    Ma, Li-Zhen
    Duan, Jun-Ting
    [J]. DIABETES THERAPY, 2024, 15 (11) : 2351 - 2366
  • [49] The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus
    Abby, Stacey L.
    Garvey, W. Timothy
    Handelsman, Yehuda
    Fonseca, Vivian A.
    Goldberg, Ronald B.
    Rosenstock, Julio
    Jones, Michael R.
    Markiewicz, Magdalena
    Jin, Xiaoping
    Misir, Soamnauth
    Nagendran, Sukumar
    [J]. DIABETES, 2010, 59 : A173 - A173
  • [50] Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
    Perez, Alfonso
    Zhao, Zhen
    Jacks, Randal
    Spanheimer, Robert
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2915 - 2923
12345